IsoPlexis : Statement of Changes in Beneficial Ownership – Form 4


Ownership Submission

FORM 4

Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:3235-0287Expires:January 31, 2005Estimated average burden hours per response…0.5

1. Name and Address of Reporting Person *

Strahley John

2. Issuer Name and Ticker or Trading Symbol
IsoPlexis Corp [ISO]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director

_____ 10% Owner

_____ Officer (give title below)

____ Other (specify below)

Chief Financial Officer /

(Last)

(First)

(Middle)

C/O ISOPLEXIS CORPORATION , 35 NE INDUSTRIAL ROAD

3. Date of Earliest Transaction (Month/Day/Year)

(Street)

BRANFORD

CT

06405

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Join/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security

2. Transaction Date (Month/Day/Year)

2A. Deemed Execution Date, if any (Month/Day/Year)

3. Transaction Code

4. Securities Acquired (A) or Disposed of (D)

5. Amount of Securities Beneficially Owned Following Reported Transaction(s)

6. Ownership Form: Direct (D) or Indirect (I)

7. Nature of Indirect Beneficial Ownership

Code

V

Amount

(A) or (D)

Price

Table II – Derivative Securities Beneficially Owned (egputs, calls, warrants, options, convertible securities)
(egputs, calls, warrants, options, convertible securities)

1. Title of Derivate Security

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code

5. Number of Derivative Securities Acquired (A) or Disposed of (D)

6. Date Exercisable and Expiration Date

7. Title and Amount of Securities Underlying Derivative Security

8. Price of Derivative Security

9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)

11. Nature of Indirect Beneficial Ownership

Code

V

(A)

(D)

Date Exercisable

Expriation Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships

Director

10% Owner

Officer

Other

Strahley John
C/O ISOPLEXIS CORPORATION
35 NE INDUSTRIAL ROAD
BRANFORD, CT06405

Chief Financial Officer

Signatures

/s/John Strahley

2022-08-18

**Signature of Reporting Person

Date

Explanation of Responses:

If the form is filed by more than one reporting person, see

Instruction 5(b)(v).

(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See

18 USC 1001 and 15 USC 78ff(a).

(1)

Time-vesting option subject to four-year vesting schedule with 25% vested on December 20, 2020 and the remainder in 36 equal monthly installments thereafter. Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See

Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Disclaimer IsoPlexis Corporation published this content on 18 August 2022 and is responsible for the information contained therein. Distributed by Public, unedited and unaltered, on18 August 2022 20:33:26 UTC

.

Publicnow 2022

All news about ISOPLEXIS CORPORATION

Analyst Recommendations on ISOPLEXIS CORPORATION

Sales 2022
20.2 M
Net income 2022
-84.2 M
Net cash 2022
22.3 M
P/E ratio 2022
-0.89x Yield 2022
Capitalization
76.8 M
76.8 M
EV / Sales 2022
2,70x EV / Sales 2023
3,31x Nbr of Employees
459 Free-Float

89.1%


Chart ISOPLEXIS CORPORATION






IsoPlexis Corporation Technical Analysis Chart |  MarketScreener

IsoPlexis Corporation Technical Analysis Chart | MarketScreener

Technical analysis trends ISOPLEXIS CORPORATION

Short Term Mid-Term
Long Term Trends Bearish Neutral

Bearish

Please enable JavaScript in your browser’s settings to use dynamic charts.

Sell

Buy Mean consensus
OUTPERFORM Number of Analysts
4 Last Close Price
1,95 $ average target price
$3.83 Spread / Average Target

Please enable JavaScript in your browser’s settings to use dynamic charts.

Leave a Comment